Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 Expected to seek DSMB approval to proceed with EUA application to the FDA in...
HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive...
Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation TORONTO, February 15, 2022 -- Revive...
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 701 subjects dosed to date Initiating enrollment activities in Turkey as part of its...
Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19 Approximately 700 subjects participated in the enrollment periodExpected to begin subject enrollment...
Revive Therapeutics Announces Published Research Results on Bucillamine as Potential Inhibitor of SARS-CoV-2 Infection Delta Variant TORONTO, November 16, 2021 -- InvestorsHub NewsWire -- Revive...
TORONTO, Sept. 21, 2021 -- InvestorsHub NewsWire -- Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life...
There are a few different events that can take place that naturally create buying pressure for a stock. One initial catalyst is when a stock is included in an ETF. By nature, the To read the full...
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 Phase 3 clinical trial ongoing with next DSMB meeting at 600 completed...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.08 | 0.08 | 0.08 | 0 | 0 | CS |
4 | 0 | 0 | 0.08 | 0.08 | 0.08 | 0 | 0 | CS |
12 | 0 | 0 | 0.08 | 0.08 | 0.08 | 0 | 0 | CS |
26 | 0 | 0 | 0.08 | 0.08 | 0.08 | 0 | 0 | CS |
52 | 0 | 0 | 0.08 | 0.08 | 0.08 | 0 | 0 | CS |
156 | 0 | 0 | 0.08 | 0.08 | 0.08 | 0 | 0 | CS |
260 | 0 | 0 | 0.08 | 0.08 | 0.08 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.